Final Phase 1b results presented at World Lung Conference highlight the potential of firmonertinib to address unmet needs in EGFR PACC mutant NSCLC Received FDA IND clearance for ARR-217, a CDH-17 ...
The Club and leading global sports investor form long-term partnership to support continued growth under CEO Miguel Ángel Gil ...
Shreyas Iyer injured his spleen while fielding against Australia in the recent ODI series. Now, a doctor from Apollo ...
Apollo Hospitals delivered another healthy quarter with a 26 per cent year-on-year rise in consolidated profit for Q2 FY26, ...
In addition, Goldman Sachs has raised India back to an Overweight position, expecting a 14% upside with an end-2026 NIFTY ...
Shreyas Iyer was discharged from a Sydney hospital after a spleen laceration with internal bleeding sustained while fielding ...